Zenas BioPharma Inc.
ZBIO | NASDAQ
$25.93
-$2.53 (-8.89%)
At close: Nov 5, 2026, 4:00 PM ET
$24.00
-$1.93 (-7.44%)
After-hours:
Nov 5, 2026, 5:53 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Cash & Equivalents | 110.64M | 319.74M | 56.86M | 67.21M |
Short-Term Investments | 232.55M | 31.02M | n/a | n/a |
Long-Term Investments | 17.27M | n/a | n/a | n/a |
Other Long-Term Assets | 13.81M | 12.86M | 7.36M | 4.33M |
Receivables | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a |
Other Current Assets | 7.98M | 5.16M | 2.95M | 1.24M |
Total Current Assets | 351.17M | 355.92M | 59.8M | 68.44M |
Property-Plant & Equipment | 1.39M | 1.19M | 1.01M | 1.8M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 32.47M | 14.05M | 8.38M | 6.14M |
Total Assets | 383.64M | 369.97M | 68.18M | 74.58M |
Account Payables | 7.11M | 17.14M | 5.4M | 5.82M |
Deferred Revenue | n/a | n/a | n/a | n/a |
Short-Term Debt | 1.12M | n/a | n/a | n/a |
Other Current Liabilities | 41.23M | 8.31M | 5.12M | 4.33M |
Total Current Liabilities | 62.65M | 57.29M | 23.26M | 25.97M |
Long-Term Debt | 78.64M | n/a | 20.3M | n/a |
Other Long-Term Liabilities | n/a | n/a | 250.09M | 240.09M |
Total Long-Term Liabilities | 78.85M | 218K | 270.64M | 240.9M |
Total Liabilities | 141.5M | 57.51M | 293.9M | 266.87M |
Total Debt | 79.96M | 1M | 21.11M | 1.53M |
Book Value | 242.14M | 312.46M | -225.72M | -192.29M |
Book Value Per Share | 5.41 | 7.48 | -5.89 | -5.02 |
Common Stock | 5K | 4K | n/a | n/a |
Retained Earnings | -765.13M | -387.39M | -230.4M | -193.28M |
Comprehensive Income | -64K | 194K | 37K | -41K |
Shareholders Equity | 242.14M | 312.46M | -225.72M | -192.29M |
Total Investments | 249.82M | 31.02M | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ZBIO